12845441ACTIVE
Incorporated: 2020-08-28
SIC: 72110
Last updated: 10 Jun 2026
T‑Cypher Bio develops novel T‑cell receptor (TCR)‑based therapeutics for the treatment of solid tumo Sign up to read more
No filings found for this company.
Companies with the most similar business descriptions.
| Shareholder | Share class | Shares | Holding |
|---|---|---|---|
| 888888888888888888888888 | 8888888888 | 8888888 | 88888 |
| 8888888888888888888888 | 8888888888 | 8888888 | 88888 |
| 88888888888888888888888888 | 8888888888 | 8888888 | 88888 |
| 888888888888888888 | 8888888888 | 888888 | 8888 |
| 8888888888888 | 88888888 | 888888 | 8888 |
Accounts not filed
| 8888888888888 | 88888888 | 888888 | 8888 |
72 shareholders on file , sign up free to see.